Talis Biomedical Corp Probability of Future Pink Sheet Price Finishing Over 0.0
Talis Biomedical's future price is the expected price of Talis Biomedical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Talis Biomedical Corp performance during a given time horizon utilizing its historical volatility. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Please specify Talis Biomedical's target price for which you would like Talis Biomedical odds to be computed.
Talis |
Talis Biomedical Target Price Odds to finish over 0.0
The tendency of Talis Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.00 | 90 days | 0.00 | close to 99 |
Based on a normal probability distribution, the odds of Talis Biomedical to move above the current price in 90 days from now is close to 99 (This Talis Biomedical Corp probability density function shows the probability of Talis Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Talis Biomedical has a beta of 0.57. This usually implies as returns on the market go up, Talis Biomedical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Talis Biomedical Corp will be expected to be much smaller as well. Additionally Talis Biomedical Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Talis Biomedical Price Density |
| Price |
Predictive Modules for Talis Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Talis Biomedical Corp. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Talis Biomedical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Talis Biomedical is not an exception. The market had few large corrections towards the Talis Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Talis Biomedical Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Talis Biomedical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.96 | |
β | Beta against Dow Jones | 0.57 | |
σ | Overall volatility | 2.41 | |
Ir | Information ratio | -0.19 |
Talis Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Talis Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Talis Biomedical Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Talis Biomedical is not yet fully synchronised with the market data | |
| Talis Biomedical generated a negative expected return over the last 90 days | |
| Talis Biomedical has high historical volatility and very poor performance | |
| Talis Biomedical has some characteristics of a very speculative penny stock | |
| Talis Biomedical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 412 K. Net Loss for the year was (62.01 M) with loss before overhead, payroll, taxes, and interest of (149.4 M). | |
| Talis Biomedical Corp currently holds about 165.37 M in cash with (53.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.21. |
Talis Biomedical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Talis Pink Sheet often depends not only on the future outlook of the current and potential Talis Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Talis Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.8 M | |
| Cash And Short Term Investments | 76.7 M |
Talis Biomedical Technical Analysis
Talis Biomedical's future price can be derived by breaking down and analyzing its technical indicators over time. Talis Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Talis Biomedical Corp. In general, you should focus on analyzing Talis Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Talis Biomedical Predictive Forecast Models
Talis Biomedical's time-series forecasting models is one of many Talis Biomedical's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Talis Biomedical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Talis Biomedical Corp
Checking the ongoing alerts about Talis Biomedical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Talis Biomedical Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Talis Biomedical is not yet fully synchronised with the market data | |
| Talis Biomedical generated a negative expected return over the last 90 days | |
| Talis Biomedical has high historical volatility and very poor performance | |
| Talis Biomedical has some characteristics of a very speculative penny stock | |
| Talis Biomedical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 412 K. Net Loss for the year was (62.01 M) with loss before overhead, payroll, taxes, and interest of (149.4 M). | |
| Talis Biomedical Corp currently holds about 165.37 M in cash with (53.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.21. |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Talis Pink Sheet
If you are still planning to invest in Talis Biomedical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talis Biomedical's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |